Dr. Paul Robinson, Queensland Children’s Hospital, Australia, spoke about transforming the Cystic Fibrosis clinical care landscape at the ERS Congress 2023 in Milan. Cystic fibrosis in the era of highly effective cystic fibrosis transmembrane conductance regulator modulator therapy Dr Robinson gave an introduction on Cystic Fibrosis, focusing on CF and modulators for the whole audience. […]
Datos de fibrosis quística
Respiralia Group calls for more support for CF research
The Respiralia Group calls for more support for CF research on World Cystic Fibrosis Day for the 30% of the collective without F508del. On the occasion of World Cystic Fibrosis Day, which is commemorated on September 8, the Respiralia Group and the Spanish Cystic Fibrosis Foundation (FuEFQ), formed by the Spanish Federation of Cystic Fibrosis […]
Update on the HIT-CF Europe research project
The European CF Association (CF Europe) has published new information on the HIT-CF Europe research project for people with CF and rare mutations. People with CF with rare mutations This project aims to evaluate the efficacy and safety of different drugs (CFTR modulators and others) in people with CF and rare mutations based on intestinal […]
